1. Market Research
  2. > Giuliani S.p.A. - Product Pipeline Review - 2013

Giuliani S.p.A. - Product Pipeline Review - 2013

  • August 2013
  • -
  • Global Markets Direct
  • -
  • 27 pages

Giuliani S.p.A. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Giuliani S.p.A. - Product Pipeline Review - 2013” provides data on the Giuliani S.p.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Giuliani S.p.A.’s corporate website, SEC filings, investor presentations and featured press releases, both from Giuliani S.p.A. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Giuliani S.p.A. - Brief Giuliani S.p.A. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Giuliani S.p.A. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Giuliani S.p.A. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Giuliani S.p.A.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Giuliani S.p.A.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Giuliani S.p.A. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Giuliani S.p.A.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Giuliani S.p.A..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Giuliani S.p.A. and identify potential opportunities in those areas.

Table Of Contents

Giuliani S.p.A. - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Giuliani S.p.A. Snapshot 5
Giuliani S.p.A. Overview 5
Key Information 5
Key Facts 5
Giuliani S.p.A. - Research and Development Overview 6
Key Therapeutic Areas 6
Giuliani S.p.A. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Giuliani S.p.A. - Pipeline Products Glance 10
Giuliani S.p.A. - Late Stage Pipeline 10
Phase III Products/Combination Treatment Modalities 10
Giuliani S.p.A. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Giuliani S.p.A. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Giuliani S.p.A. - Drug Profiles 13
GED-0301 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
GED-0408 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
GED-0414 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
GED-0507 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
mesalamine ER 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
Giuliani S.p.A. - Pipeline Analysis 18
Giuliani S.p.A. - Pipeline Products by Therapeutic Class 18
Giuliani S.p.A. - Pipeline Products By Target 19
Giuliani S.p.A. - Pipeline Products by Route of Administration 20
Giuliani S.p.A. - Pipeline Products By Mechanism of Action 21
Giuliani S.p.A. - Recent Pipeline Updates 22
Giuliani S.p.A. - Dormant Projects 23
Giuliani S.p.A. - Discontinued Pipeline Products 24
Discontinued Pipeline Product Profiles 24
mesalamine ER 24
Giuliani S.p.A. - Locations And Subsidiaries 25
Head Office 25
Other Locations and Subsidiaries 25
Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 27
Disclaimer 27



List of Tables

Giuliani S.p.A., Key Information 5
Giuliani S.p.A., Key Facts 5
Giuliani S.p.A. - Pipeline by Indication, 2013 7
Giuliani S.p.A. - Pipeline by Stage of Development, 2013 8
Giuliani S.p.A. - Monotherapy Products in Pipeline, 2013 9
Giuliani S.p.A. - Phase III, 2013 10
Giuliani S.p.A. - Phase II, 2013 11
Giuliani S.p.A. - Preclinical, 2013 12
Giuliani S.p.A. - Pipeline By Therapeutic Class, 2013 18
Giuliani S.p.A. - Pipeline By Target, 2013 19
Giuliani S.p.A. - Pipeline By Route of Administration, 2013 20
Giuliani S.p.A. - Pipeline Products By Mechanism of Action, 2013 21
Giuliani S.p.A. - Recent Pipeline Updates, 2013 22
Giuliani S.p.A. - Dormant Developmental Projects,2013 23
Giuliani S.p.A. - Discontinued Pipeline Products, 2013 24
Giuliani S.p.A., Subsidiaries 25



List of Figures

Giuliani S.p.A. - Pipeline by Indication, 2013 7
Giuliani S.p.A. - Pipeline by Stage of Development, 2013 8
Giuliani S.p.A. - Monotherapy Products in Pipeline, 2013 9
Giuliani S.p.A. - Pipeline By Therapeutic Class, 2013 18
Giuliani S.p.A. - Pipeline Products By Mechanism of Action, 2013 21



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.